Opportunities and pitfalls of molecular testing for detecting sexually transmitted pathogens

Pathology

Volumn 47, Issue 3, 2015, Pages 219-226

  Trembizki, Ella ^a   Costa, Anna Maria G ^b,c   Tabrizi, Sepehr N ^b,c,d,e   Whiley, David M ^a   Twin, Jimmy ^b,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chlamydia; gonorrhoea; molecular; mycoplasma; NAAT; PCR; trichomonas

Indexed keywords

HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR DIAGNOSIS; SEXUALLY TRANSMITTED DISEASES;

HUMANS; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; SEXUALLY TRANSMITTED DISEASES;

EID: 84949633012     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000239     Document Type: Article

References (105)

1. 1. Rours, G.I., Duijts, L., Moll, H.A., et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. Eur J Epidemiol 26 (2011), 493–502.
2. 2. Keat, A., Thomas, B., Dixey, J., et al. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1 (1987), 72–74.
3. 3. Grayston, J.T., Wang, S., New knowledge of chlamydiae and the diseases they cause. J Infect Dis 132 (1975), 87–105.
4. 4. WHO Alliance for the Global Elimination of Blinding Trachoma by the Year 2020. Progress report on elimination of trachoma, 2013. Wkly Epidemiol Rec 89 (2014), 421–428.
5. 5. Rours, IGIJG, Hammerschlag, M.R., Ott, A., et al. Chlamydia trachomatis as a cause of neonatal conjunctivitis in Dutch infants. Pediatrics 121 (2008), e321–e326.
6. 6. Hafner, L.M., Pelzer, E.S., Kamrava, M.R., (eds.) Ectopic Pregnancy - Modern Diagnosis and Management, 2011, InTech, Rijeka, Croatia http://www.intechopen.com/books/ectopic-pregnancy-modern-diagnosis-and-management/tubal-damage-inferti lity-and-tubal-ectopic-pregnancy-chlamydia-trachomatis-and-other-microbial-aetio.
7. 7. Haggerty, C.L., Gottlieb, S.L., Taylor, B.D., et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 201:Suppl 2 (2010), S134–S155.
8. 8. Land, J.A., Van Bergen, J.E.A.M., Morre, S.A., et al. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update 16 (2010), 189–204.
9. 9. Martinez, M.A., Millan, F., Gonzalez, C., Chlamydia trachomatis genotypes associated with pneumonia in Chilean infants. Scand J Infect Dis 41 (2009), 313–316.
10. 10. Lopez-Vicente, J., Rodriguez-Alcalde, D., Hernandez-Villalba, L., et al. Proctitis as the clinical presentation of lymphogranuloma venereum, a re-emerging disease in developed countries. Rev Esp Enferm Dig 106 (2014), 59–62.
11. 11. Nelson, H.D., Zakher, B., Cantor, A., et al. Screening for Gonorrhea and Chlamydia: Systematic Review to Update the US Preventive Services Task Force Recommendations, 2014, Agency for Healthcare Research and Quality, Rockville, MD Evidence Synthesis No. 115. AHRQ Publication No. 13-05184-EF-1.
12. 12. Ripa, T., Nilsson, P., A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill, 11, 2006, E061109.
13. 13. Ripa, T., Nilsson, P.A.A., Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests. Sex Transm Dis 34 (2007), 255–256.
14. 14. Pineiro, L., Bernal, S., Bordes, A., et al. Minimum spread of the new Swedish variant of Chlamydia trachomatis and distribution of trachomatis ompA genotypes in three geographically distant areas of Spain, 2011-2012. Infection 42 (2014), 905–912.
15. 15. Fieser, N., Simnacher, U., Tausch, Y., et al. Chlamydia trachomatis prevalence, genotype distribution and identification of the new Swedish variant in Southern Germany. Infection 41 (2013), 159–166.
16. 16. Niemi, S., Hiltunen-Back, E., Puolakkainen, M., Chlamydia trachomatis genotypes and the Swedish new variant among urogenital Chlamydia trachomatis strains in Finland. Infect Dis Obstet Gynecol, 2011, 2011, 481890.
17. 17. Whiley, D.M., Sloots, T.P., Comparison of three in-house multiplex PCR assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis using real-time and conventional detection methodologies. Pathology 37 (2005), 364–370.
18. 18. Guy, R.J., Natoli, L., Ward, J., et al. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO - the “TTANGO” trial protocol. BMC Infect Dis, 13, 2013, 485.
19. 19. Natoli, L., Maher, L., Shephard, M., et al. Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice. PLoS One, 9, 2014, e100518.
20. 20. Hui, B.B., Wilson, D.P., Ward, J.S., et al. The potential impact of new generation molecular point-of-care tests on gonorrhoea and chlamydia in a setting of high endemic prevalence. Sex Health 10 (2013), 348–356.
21. 21. Shafer, M.-A., Moncada, J., Boyer, C.B., et al. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test. J Clin Microbiol 41 (2003), 4395–4399.
22. 22. Knox, J., Tabrizi, S.N., Miller, P., et al. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by poly-merase chain reaction among women living in remote areas. Sex Transm Dis 29 (2002), 647–654.
23. 23. Tabrizi, S.N., Paterson, B.A., Fairley, C.K., et al. Comparison of tampon and urine as self-administered methods of specimen collection in the detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women. Int J STD AIDS 9 (1998), 347–349.
24. 24. Costa, A.M., Fairley, C.K., Garland, S.M., et al. Evaluation of self-collected urine dip swab method for detection of Chlamydia trachomatis. Sex Health 6 (2009), 213–216.
25. 25. Gaydos, C.A., Farshy, C., Barnes, M., et al. Can mailed swab samples be dryshipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests?. Diagn Microbiol Infect Dis 73 (2012), 16–20.
26. 26. Zhu, H., Wang, H.P., Jiang, Y., et al. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage. Andrologia 42 (2010), 274–280.
27. 27. Kong, F.Y., Tabrizi, S.N., Law, M., et al. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. Clin Infect Dis 59 (2014), 193–205.
28. 28. Hillis, S.D., Owens, L.M., Marchbanks, P.A., et al. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 176 (1997), 103–107.
29. 29. Oud, E.V., de Vrieze, N.H., de Meij, A., Pitfalls in the diagnosis and management of inguinal lymphogranuloma venereum: important lessons from a case series. Sex Transm Infect 90 (2014), 279–282.
30. 30. de Vries, H.J., Smelov, V., Middelburg, J.G., et al. Delayed microbial cure of lymphogranuloma venereum proctitis with doxycycline treatment. Clin Infect Dis 48 (2009), e53–e56.
31. 31. Dukers-Muijrers, N.H., Morre, S.A., Speksnijder, A., et al. Chlamydia trachomatis test-of-cure cannot be based on a single highly sensitive laboratory test taken at least 3 weeks after treatment. PLoS One, 7, 2012, e34108.
32. 32. World Health Organization (WHO). Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae, 2012, WHO, Geneva http://whqlibdoc.who.int/publications/2012/9789241503501_eng.pdf.
33. 33. Trembizki, E., Lahra, M., Stevens, K., et al. A national quality assurance survey of Neisseria gonorrhoeae testing. J Med Microbiol 63 (2014), 45–49.
34. 34. Ohnishi, M., Golparian, D., Shimuta, K., et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 55 (2011), 3538–3545.
35. 35. Unemo, M., Golparian, D., Nicholas, R., et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: Novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 56 (2012), 1273–1280.
36. 36. Ohnishi, M., Saika, T., Hoshina, S., et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis 17 (2011), 148–149.
37. 37. Unemo, M., Shafer, W.M., Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 27 (2014), 587–613.
38. 38. Whiley, D.M., Tapsall, J.W., Sloots, T.P., Nucleic acid amplification testing for Neisseria gonorrhoeae - An ongoing challenge. J Mol Diagn 8 (2006), 3–15.
39. 39. Linz, B., Schenker, M., Zhu, P.X., et al. Frequent interspecific genetic exchange between commensal neisseriae and Neisseria meningitidis. Mol Microbiol 36 (2000), 1049–1058.
40. 40. Smith, D.W., Tapsall, J.W., Lum, G., Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network. Commun Dis Intell Q Rep 29 (2005), 358–365.
41. 41. Lum, G., Freeman, K., Nguyen, N.L., et al. A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR. Sex Transm Infect 81 (2005), 400–402.
42. 42. Geraats-Peters, C.W.M., Brouwers, M., Schneeberger, P.M., et al. Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by realtime PCR. J Clin Microbiol 43 (2005), 5653–5659.
43. 43. Golparian, D., Johansson, E., Unemo, M., Clinical Neisseria gonorrhoeae isolate with a meningitidis porA gene and no prolyliminopeptidase activity, Sweden 2011: danger of false-negative genetic and culture diagnostic results. Euro Surveill 17 (2012), 5–7.
44. 44. Whiley, D.M., Limnios, A., Moon, N.J., False-negative results using Neisseria gonorrhoeae porA pseudogene PCR – a clinical gonococcal isolate with an . meningitidis porA sequence, Australia, March 2011. Euro Surveill 16 (2011), 5–8.
45. 45. Eastick, K., Winter, A., Jamdar, S., Identification of Neisseria gonorrhoeae isolates with a recombinant porA gene in Scotland, United Kingdom, 2010 to 2011. Euro Surveill 17 (2012), 2–4.
46. 46. Ison, C.A., Golparian, D., Saunders, P., et al. Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcal porA mutants are spreading internationally. Sex Transm Infect 89 (2013), 197–201.
47. 47. Goire, N., Nissen, M.D., LeCornec, G.M., et al. A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy Opa genes. Diagn Microbiol Infect Dis 61 (2008), 6–12.
48. 48. Lahra, M.M., Ryder, N., Whiley, D.M., A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med 371 (2014), 1850–1851.
49. 49. Su, J., Pell, C., Evidence for a sharp decrease in gonococcal cultures and its implications for the surveillance of antimicrobial sensitivity. Northern Territory Dis Control Bull 16 (2009), 11–14.
50. 50. Goire, N., Freeman, K., Tapsall, J.W., et al. Enhancing gonococcal antimicrobial resistance surveillance: a real-time pcr assay for detection of penicillinase-producing Neisseria gonorrhoeae by use of noncultured clinical samples. J Clin Microbiol 49 (2011), 513–518.
51. 51. Goire, N., Ohnishi, M., Limnios, A.E., et al. Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain. J Antimicrob Chemother 67 (2012), 902–905.
52. 52. Goire, N., Freeman, K., Lambert, S.B., et al. The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance. Sex Health 9 (2012), 422–429.
53. 53. Speers, D.J., Fisk, R.E., Goire, N., et al. Non-culture Neisseria gonorrhoeae molecular penicillinase production surveillance demonstrates the long-term success of empirical dual therapy and informs gonorrhoea management guidelines in a highly endemic setting. J Antimicrob Chemother 69 (2014), 1243–1247.
54. 54. Bignell, C., FitzGerald, M., UK National Guideline for the Management of Gonorrhoea in Adults, 2011. Int J STD AIDS 22 (2011), 541–547.
55. 55. Bissessor, M., Whiley, D.M., Fairley, et al. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea among isolates is influenced by antibiotic susceptibility and re-infection. Clin Infect Dis 60 (2015), 557–563.
56. 56. Tully, J.G., Taylor-Robinson, D., Cole, R.M., et al. A newly discovered mycoplasma in the human urogenital tract. Lancet 1 (1981), 1288–1291.
57. 57. Jensen, J.S., Mycoplasma genitalium infections. Diagnosis, clinical aspects, and pathogenesis. Dan Med Bull 53 (2006), 1–27.
58. 58. Horner, P.J., Taylor-Robinson, D., Association of Mycoplasma genitalium with balanoposthitis in men with non-gonococcal urethritis. Sex Transm Infect 87 (2011), 38–40.
59. 59. Manhart, L.E., Mostad, S.B., Baeten, J.M., et al. High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. J Infect Dis 197 (2008), 733–736.
60. 60. Mavedzenge, S.N., Weiss, H.A., Association of Mycoplasma genitalium and HIV infection: A systematic review and meta-analysis. AIDS 23 (2009), 611–620.
61. 61. Zheng, B.J., Yin, Y.P., Han, Y., et al. The prevalence of urethral and rectal Mycoplasma genitalium among men who have sex with men in China, a cross-sectional study. BMC Public Health, 14, 2014, 195.
62. 62. Annan, N.T., Sullivan, A.K., Nori, A., et al. Rectal chlamydia–a reservoir of undiagnosed infection in men who have sex with men. Sex Transm Infect 85 (2009), 176–179.
63. 63. Daley, G., Russell, D., Tabrizi, S., et al. Mycoplasma genitalium: a review. Int J STD AIDS 25 (2014), 475–487.
64. 64. Salado-Rasmussen, K., Jensen, J.S., Mycoplasma genitalium testing pattern and macrolide resistance: A Danish nationwide retrospective survey. Clin Infect Dis 59 (2014), 24–30.
65. 65. McGowin, C.L., Anderson-Smits, C., Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog, 7, 2011, e1001324.
66. 66. Jensen, J.S., Bjornelius, E., Dohn, B., et al. Use of TaqMan 5’ nuclease realtime PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. J Clin Microbiol 42 (2004), 683–692.
67. 67. Twin, J., Taylor, N., Garland, S.M., et al. Comparison of two Mycoplasma genitalium real-time pcr detection methodologies. J Clin Microbiol 49 (2011), 1140–1142.
68. 68. Svenstrup, H.F., Jensen, J.S., Bjornelius, E., et al. Development of a quantitative real-time PCR assay for detection of Mycoplasma genitalium. J Clin Microbiol 43 (2005), 3121–3128.
69. 69. Svenstrup, H.F., Dave, S.S., Carder, C., et al. A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London. BMJ Open, 4, 2014, e003947.
70. 70. Walker, J., Fairley, C.K., Bradshaw, C.S., et al. Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. Clin Infect Dis 56 (2013), 1094–1100.
71. 71. Lillis, R.A., Nsuami, M.J., Myers, L., et al. Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women. J Clin Microbiol 49 (2011), 1990–1992.
72. 72. Jernberg, E., Moghaddam, A., Moi, H., Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 19 (2008), 676–679.
73. 73. Bjornelius, E., Anagrius, C., Bojs, G., et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 84 (2008), 72–76.
74. 74. Wikström, A., Jensen, J.S., Mycoplasma genitalium: A common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect 82 (2006), 276–279.
75. 75. Mena, L.A., Mroczkowski, T.F., Nsuami, M., et al. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 48 (2009), 1649–1654.
76. 76. Schwebke, J.R., Rompalo, A., Taylor, S., Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens–a randomized clinical trial. Clin Infect Dis 52 (2011), 163–170.
77. 77. Gesink, D.C., Mulvad, G., Montgomery-Andersen, R., et al. Mycoplasma genitalium presence, resistance and epidemiology in Greenland. Int J Circumpolar Health 71 (2012), 1–8.
78. 78. Anagrius, C., Loré, B., Jensen, J.S., Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic. PLoS One, 8, 2014, e61481.
79. 79. Bradshaw, C.S., Jensen, J.S., Tabrizi, S.N., et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 12 (2006), 1149–1152.
80. 80. Manhart, L.E., Broad, J.M., Golden, M.R., Mycoplasma genitalium: Should we treat and how?. Clin Infect Dis 53 (2011), S129–S142.
81. 81. Shimada, Y., Deguchi, T., Nakane, K., et al. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance. Int J Antimicrob Agents 36 (2010), 255–258.
82. 82. Couldwell, D.L., Tagg, K.A., Jeoffreys, N.J., et al. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS 24 (2013), 822–828.
83. 83. Twin, J., Jensen, J.S., Bradshaw, C.S., et al. Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PLoS One, 7, 2012, e35593.
84. 84. Touati, A., Peuchant, O., Jensen, J.S., et al. Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis. J Clin Microbiol 52 (2014), 1549–1555.
85. 85. Peuchant, O., Menard, A., Renaudin, H., et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother 64 (2009), 52–58.
86. 86. Kikuchi, M., Ito, S., Yasuda, M., et al. Remarkable increase in fluoroquino-lone-resistant Mycoplasma genitalium in Japan. J Antimicrob Chemother 69 (2014), 2376–2382.
87. 87. Yamaguchi, Y., Takei, M., Kishii, R., et al. Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium. Antimicrob Agents Chemother 57 (2013), 1772–1776.
88. 88. Cotch, M.F., Pastorek, J.G., Nugent, R.P., et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 24 (1997), 353–360.
89. 89. McClelland, R.S., Sangare, L., Hassan, W.M., et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 195 (2007), 698–702.
90. 90. Smith, K.S., Tabrizi, S.N., Fethers, K.A., et al. Comparison of conventional testing to polymerase chain reaction in detection of Trichomonas vaginalis in indigenous women living in remote areas. Int J STD AIDS 16 (2005), 811–815.
91. 91. Wangnapi, R.A., Soso, S., Unger, H.W., et al. Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infectioninpregnant womeninPapua New Guinea. Sex Transm Infect, 2014.
92. 92. Patil, M.J., Nagamoti, J.M., Metgud, S.C., Diagnosis of Trichomonas vaginalis from vaginal specimens by wet mount microscopy, in pouch TV culture system, and PCR. J Global Infect Dis 4 (2012), 22–25.
93. 93. Hobbs, M.M., Sena, A.C., Modern diagnosis of Trichomonas vaginalis infection. Sex Transm Infect 89 (2013), 434–438.
94. 94. Muzny, C.A., Schwebke, J.R., The clinical spectrum of Trichomonas vaginalis infection and challenges to management. Sex Transm Infect 89 (2013), 423–425.
95. 95. Paulish-Miller, T.E., Augostini, P., Schuyler, J.A., et al. Trichomonas vaginalis metronidazole resistance is associated with single nucleotide polymorphisms in the nitroreductase genes ntr4Tv and ntr6Tv. Antimicrob Agents Chemother 58 (2014), 2938–2943.
96. 96. Upcroft, J.A., Dunn, L.A., Wal, T., et al. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea. Sex Health 6 (2009), 334–338.
97. 97. Simpson, P., Higgins, G., Qiao, M., et al. Real-time PCRs for detection of Trichomonas vaginalis beta-tubulin and 18S rRNA genes in female genital specimens. J Med Microbiol 56 (2007), 772–777.
98. 98. Siedner, M.J., Pandori, M., Castro, L., et al. Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples. J Clin Microbiol 45 (2007), 1250–1254.
99. 99. Magooa, M.P., Muller, E.E., Gumede, L., Lewis, D.A., Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay. Int J Antimicrob Agents 42 (2013), 63–67.
100. 100. Tabrizi, S.N., Unemo, M., Limnios, A.E., et al. Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species. J Clin Microbiol 49 (2011), 3610–3615.
101. 101. Caliendo, A.M., Jordan, J.A., Green, A.M., Ingersoll, J., Diclemente, R.J., Wingood, G.M., Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect Dis Obstet Gynecol 13 (2005), 145–150.
102. 102. Kengne, P., Veas, F., Vidal, N., Rey, J.L., Cuny, G., Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol 40 (1994), 819–831.
103. 103. Lawing, L.F., Hedges, S.R., Schwebke, J.R., Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR. J Clin Microbiol 38 (2000), 3585–3588.
104. 104. Madico, G., Quinn, T.C., Rompalo, A., McKee, K.T. Jr., Gaydos, C.A., Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 36 (1998), 3205–3210.
105. 105. Mayta, H., Gilman, R.H., Calderon, M.M., et al. 18S ribosomal DNA-based PCR for diagnosis of Trichomonas vaginalis. J Clin Microbiol 38 (2000), 2683–2687.